Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 8257 

National Center for Emerging and 

Zoonotic Infectious Diseases, CDC, 1600 

Clifton Road NE, Mailstop H16–3, 

Atlanta, Georgia 30329–4027, 

Telephone: (404) 718–8039; Email: 

HICPAC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion (DHQP), the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC, the Secretary, Health 

and Human Services regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters to be Considered: The agenda 

will include the following updates: The 

Healthcare Personnel Guideline 

Workgroup; the Isolation Precautions 

Guideline Workgroup; and the Neonatal 

Intensive Care Unit Workgroup. Agenda 

items are subject to change as priorities 

dictate. 

Procedures for Public Comment: Time 

will be available for public comment. 

Members of the public who wish to 

provide public comments should plan 

to attend the public comment session at 

the start time listed. Please note that the 

public comment period may end before 

the time indicated, following the last 

call for comments. 

Procedures for Written Comment: The 

public may submit written comments in 

advance of the meeting. Comments 

should be submitted in writing by email 

to the contact person listed above. The 

deadline for receipt of written public 

comment is March 18, 2022. All 

requests must contain the name, 

address, and organizational affiliation of 

the speaker, as well as the topic being 

addressed. Written comments should 

not exceed one single-spaced typed page 

in length. Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–03038 Filed 2–11–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–0728; Docket No. CDC–2022– 

0020] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled National Notifiable Diseases 

Surveillance System (NNDSS). The 

purpose of this data collection is to 

provide the official source of statistics 

in the United States for nationally 

notifiable conditions. 

DATES: CDC must receive written 

comments on or before April 15, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0020 by either of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Notifiable Diseases 

Surveillance System (NNDSS) (OMB 

Control No. 0920–0728, Exp. 3/31/ 

2024)—Revision—Center for 

Surveillance, Epidemiology and 

Laboratory Services (CSELS), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Public Health Services Act (42 

U.S.C. 241) authorizes CDC to 

disseminate nationally notifiable 

condition information. The National 


jspears on DSK121TN23PROD with NOTICES1
8258 Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 

Notifiable Diseases Surveillance System 

(NNDSS) is based on data collected at 

the state, territorial and local levels 

because of legislation and regulations in 

those jurisdictions that require health 

care providers, medical laboratories, 

and other entities to submit healthrelated data on reportable conditions to 

public health departments. These 

reportable conditions, which include 

infectious and non-infectious diseases, 

vary by jurisdiction depending upon 

each jurisdiction’s health priorities and 

needs. Each year, the Council of State 

and Territorial Epidemiologists (CSTE), 

supported by CDC, determines which 

reportable conditions should be 

designated nationally notifiable or 

under standardized surveillance. 

CDC requests a three-year approval for 

a Revision for the NNDSS (OMB Control 

No. 0920–0728, Expiration Date 03/31/ 

2024). 

This Revision includes requests for 

approval to: (1) Receive case notification 

data for Alpha-gal syndrome (AGS), a 

new condition under standardized 

surveillance (CSS); (2) receive Sexual 

Orientation and Gender Identity (SOGI) 

and Birth Sex data elements (with 

United States Core Data for 

Interoperability (USCDI) value sets) for 

sexually transmitted diseases (STD) and 

Hepatitis; (3) receive an extension of 

three years to continue to receive the 

current SOGI data elements for STD; 

and (4) receive new disease-specific 

data elements for Hepatitis and AGS. 

The NNDSS currently facilitates the 

submission and aggregation of case 

notification data voluntarily submitted 

to CDC from 60 jurisdictions: Public 

health departments in every U.S. state, 

New York City, Washington DC, five 

U.S. territories (American Samoa, the 

Commonwealth of Northern Mariana 

Islands, Guam, Puerto Rico, and the U.S. 

Virgin Islands), and three freely 

associated states (Federated States of 

Micronesia, the Republic of the 

Marshall Islands, and the Republic of 

Palau). This information is shared 

across jurisdictional boundaries and 

both surveillance and prevention and 

control activities are coordinated at 

regional and national levels. 

Approximately 90% of case 

notifications are encrypted and 

submitted to NNDSS electronically from 

already existing databases by automated 

electronic messages. When automated 

transmission is not possible, case 

notifications are faxed, emailed, 

uploaded to a secure network or entered 

into a secure website. All case 

notifications that are faxed or emailed 

are done so in the form of an aggregate 

weekly or annual report, not individual 

cases. These different mechanisms used 

to send case notifications to CDC vary 

by the jurisdiction and the disease or 

condition. Jurisdictions remove most 

personally identifiable information (PII) 

before data are submitted to CDC, but 

some data elements (e.g., date of birth, 

date of diagnosis, county of residence) 

could potentially be combined with 

other information to identify 

individuals. Private information is not 

disclosed unless otherwise compelled 

by law. All data are treated in a secure 

manner consistent with the technical, 

administrative, and operational controls 

required by the Federal Information 

Security Management Act of 2002 

(FISMA) and the 2010 National Institute 

of Standards and Technology (NIST) 

Recommended Security Controls for 

Federal Information Systems and 

Organizations. Weekly tables of 

nationally notifiable diseases are 

available through CDC WONDER and 

data.cdc.gov. Annual summaries of 

finalized nationally notifiable disease 

data are published on CDC WONDER 

and data.cdc.gov and disease-specific 

data are published by individual CDC 

programs. 

The burden estimates include the 

number of hours that the public health 

department uses to process and send 

case notification data from their 

jurisdiction to CDC. Specifically, the 

burden estimates include separate 

burden hours incurred for automated 

and non-automated transmissions, 

separate weekly burden hours incurred 

for modernizing surveillance systems as 

part of NNDSS Modernization Initiative 

(NMI) implementation, separate burden 

hours incurred for annual data 

reconciliation and submission, and 

separate one-time burden hours 

incurred for the addition of new 

diseases and data elements. The burden 

estimates for the one-time burden for 

reporting jurisdictions are for the 

addition of case notification data for 

Alpha-gal syndrome (AGS), a new 

condition under standardized 

surveillance (CSS); Sexual Orientation 

and Gender Identity (SOGI) and Birth 

Sex data elements for sexually 

transmitted diseases (STD) and 

Hepatitis; and new disease-specific data 

elements for Hepatitis and AGS. The 

estimated annual burden for the 257 

respondents is 18,294 hours, which has 

decreased from the previously-approved 

18,954 hours in the last Revision. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

States ................................................ Weekly (Automated) ......................... 50 52 20/60 867 

States ................................................ Weekly (Non-automated) ................. 10 52 2 1,040 

States ................................................ Weekly (NMI Implementation) .......... 50 52 4 10,400 

States ................................................ Annual .............................................. 50 1 75 3,750 

States ................................................ One-time Addition of Diseases and 

Data Elements.

50 1 1 50 

Territories .......................................... Weekly (Automated) ......................... 5 52 20/60 87 

Territories .......................................... Weekly, Quarterly (Non-automated) 5 56 20/60 93 

Territories .......................................... Weekly (NMI Implementation) .......... 5 52 4 1,040 

Territories .......................................... Annual .............................................. 5 1 5 25 

Territories .......................................... One-time Addition of Diseases and 

Data Elements.

5 1 1 5 

Freely Associated States .................. Weekly (Automated) ......................... 3 52 20/60 52 

Freely Associated States .................. Weekly, Quarterly (Non-automated) 3 56 20/60 56 

Freely Associated States .................. Annual .............................................. 3 1 5 15 

Freely Associated States .................. One-time Addition of Diseases and 

Data Elements.

3 1 1 3 

Cities ................................................. Weekly (Automated) ......................... 2 52 20/60 35 

Cities ................................................. Weekly (Non-automated) ................. 2 52 2 208 

Cities ................................................. Weekly (NMI Implementation) .......... 2 52 4 416 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 8259 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Cities ................................................. Annual .............................................. 2 1 75 150 

Cities ................................................. One-time Addition of Diseases and 

Data Elements.

2 1 1 2 

Total ........................................... ........................................................... ........................ ........................ ........................ 18,294 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–03078 Filed 2–11–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–2022–1050; Docket No. CDC–2022– 

0025] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled CDC/ATSDR Generic Clearance 

for the Collection of Qualitative 

Feedback on Agency Service Delivery. 

The information collection activities 

provide a means to garner qualitative 

customer and stakeholder feedback in 

an efficient, timely manner, in 

accordance with the federal 

government’s commitment to improving 

service delivery. 

DATES: CDC must receive written 

comments on or before April 15, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0025 by either of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(Regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

CDC/ATSDR Generic Clearance for 

the Collection of Qualitative Feedback 

on Agency Service Delivery (OMB 

Control No. 0920–1050, Exp. 5/31/ 

2022)—Extension—Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The information collection activities 

associated with this Generic clearance 

provide a means to garner qualitative 

customer and stakeholder feedback in 

an efficient, timely manner, in 

accordance with the federal 

government’s commitment to improving 

service delivery. By qualitative 

feedback, information will be collected 

that provides useful insights on 

perceptions and opinions, but are not 

statistical surveys that yield quantitative 

results that can be generalized to the 

population of study. 

Feedback from respondents will 

provide insights into customer or 

stakeholder perceptions, experiences 

and expectations, provide an early 

warning of issues with service, or focus 

attention on areas where 

communication, training or changes in 

operations might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between 

CDC and its customers and 

stakeholders. It will also allow feedback 

to contribute directly to the 

improvement of program management. 

The solicitation of feedback will target 

areas such as: Timeliness, 


jspears on DSK121TN23PROD with NOTICES1